eCite Digital Repository

Nasal continuous positive airway pressure treatment: current realities and future

Citation

Bethon-Jones, M and Lawrence, SJ and Sullivan, CE and Grunstein, R, Nasal continuous positive airway pressure treatment: current realities and future, Sleep, 19, (9 (Suppl)) pp. S131-S135. ISSN 0161-8105 (1996) [Refereed Article]

Copyright Statement

Copyright 1996 American Sleep Disorders Association and Sleep Research Society

Official URL: http://www.journalsleep.org/

DOI: doi:10.1093/sleep/19.suppl_9.S131

Abstract

Nasal continuous positive airway pressure (CPAP) is a highly effective treatment for obstructive sleep apnea syndrome. The apnea/hypopnea index (AHI) is reduced 10-fold, but the patient dropout rate is up to 30%, and usage is typically < 5 hours per night. Titration, designed to make the best trade-off between effectiveness and side effects, is expensive. Autotitrating devices make this trade-off on a minute-by-minute basis, potentially reducing mean pressure delivery, reducing side effects, and increasing compliance. The aim of this study was to test the effectiveness of the AutoSet self-adjusting nasal CPAP system (ResMed, Sydney, Australia) in eliminating obstructive events and normalizing the arousal index. Forty-five subjects (41 males and 4 females with AHI) values of > 20/hour were recruited, with written informed consent. Subjects slept for a diagnostic night, followed by a treatment night, in the laboratory, using the AutoSet system with full polysomnographic monitoring of respiratory and sleep variables. Arousals were scored using ASDA criteria. Hypopneas were scored when there was a 50% reduction in ventilation for > 10 seconds, associated with a 4% drop in oxygen saturation. For comparison, the ASDA arousal index in 16 normal subjects (without nasal CPAP) is provided. Results are given as mean +/- standard error of the mean. AHI was reduced from 55 +/- 3 to 1.5 +/- 0.35 events/hour (p < 0.0001). The arousal index was reduced from 65 +/- 3 to 18 +/- 2 events/hour (p < 0.0001), identical to the value in the 16 healthy normal subjects. There was a 158% +/- 21% increase in slow-wave sleep (p = 0.01) and a 186% +/- 27% increase in rapid eye movement sleep (p = 0.013). The AutoSet self-adjusting nasal CPAP system adequately treats obstructive sleep apnea syndrome on the first night under laboratory conditions.

Item Details

Item Type:Refereed Article
Keywords:sleep apnea, CPAP
Research Division:Medical and Health Sciences
Research Group:Cardiorespiratory Medicine and Haematology
Research Field:Respiratory Diseases
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Respiratory System and Diseases (incl. Asthma)
Author:Lawrence, SJ (Dr Suanne Lawrence)
ID Code:104782
Year Published:1996
Web of Science® Times Cited:43
Deposited By:Health Sciences
Deposited On:2015-11-19
Last Modified:2017-12-13
Downloads:0

Repository Staff Only: item control page